Heidi Hau, PhD, joins our team as Vice President Scientific Affairs & Partnerships

Copenhagen, 11 January 2023 – We are beyond excited to announce that Heidi Hau, PhD, has joined our team as Vice President, Scientific Affairs & Partnerships, to lead the expansion of our US Business.

Heidi holds a PhD in microbiology and immunology and has worked across scientific and business development groups directing global innovation and leading technical due diligence for external partnerships within microbiological and molecular-based technologies. Most recently, Heidi led key initiatives at Rebiotix (a Ferring company) to expand investigational microbiota-based drug platforms for the treatment of infectious and chronic diseases. In this role, Heidi led the Translational Biology team that was responsible for microbiome analyses and integration of microbiome discoveries across R&D and clinical research enabling new and improved scientific understanding of microbiota-based therapeutics. She also managed investigator-sponsored clinical studies.

Heidi will lead our business and scientific activities in the US, including development strategies, external partnerships and CRO organization and execution. With experience from leading cross-functional R&D and translational biology programs across pharma, biotech start-ups and Fortune 500 companies, we are thrilled to have Heidi on our team to grow our activities and support our partners in the US.

If you are involved in microbiome research projects in the US, feel free to contact Heidi directly.

Get in touch

Tell us about your study.

Please enable JavaScript in your browser to complete this form.